BDT snaps up minority stake in Exyte

Exyte serves clients in the markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centres. 

  • Exyte is a company for design, engineering, procurement, and construction in controlled and regulated environments
  • Georg Stumpf, Exyte’s sole owner, will retain a majority stake
  • Exyte targets sales of €10bn in 2027

BDT Capital Partners announced it has entered into an agreement to acquire a “significant” minority interest in Exyte. Georg Stumpf, Exyte’s sole owner, will retain a majority stake.

Stuttgart-based Exyte is a company for design, engineering, procurement, and construction in controlled and regulated environments. It serves clients in the markets of semiconductors, battery cells, pharmaceuticals, biotechnology and data centres.

“Exyte is a leader in the design, development, and delivery of the world’s most sophisticated manufacturing environments,” said Don McLellan, partner at BDT. “The company plays an indispensable role enabling clients across semiconductor, biopharma, life sciences, and cloud computing industries to create best-in-class facilities where technological breakthroughs happen. Due to the strong leadership of Exyte’s management team and the dedication of its talented employees in serving the needs of its clients, the company has an impressive track record of profitable growth.”

BDT, headquartered in Chicago, is an affiliate of the merchant bank BDT & Company. BDT has deployed more than $30 billion in capital through its investment funds and co-investments.